The table below shows GoodRx Holdings, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$167.90M
$183.89M
$138.29M
$146.78M
$178.78M
$131.34M
Capital expenditure
$3.52M
$1.24M
$1.04M
$3.97M
$4.57M
$20.55M
Investing cash flow
-$119.96M
-$70.35M
-$55.77M
-$210.50M
-$178.73M
-$91.62M
Dividends paid
-
-
-
-
-
GDRX operating cash flow (10-K history)
GoodRx Holdings, Inc. reported operating cash flow of $167.90M for fiscal year 2025. That is down 8.7% from $183.89M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from $45.25M (FY 2018) to $167.90M. Figures come from the company's audited annual reports as filed with the SEC.
